Congress orders study on why gynecologic patients can't get pain relief
H.R. 8159 — Gynecologic Pain Management Study Act · Filed by Yassamin Ansari (D-AZ) · 28 cosponsors · Introduced Mar 30, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Department of Health and Human Services to study why patients undergoing gynecologic procedures often lack access to pain management options. The study will examine barriers such as insurance coverage gaps, provider training deficiencies, and resource constraints, and will consult patients, doctors, medical societies, and device makers. HHS must report findings and recommendations to Congress within 24 months.
Why we flagged it
The bill is a straightforward directive for a government study on a documented healthcare access gap. It creates no new programs, subsidies, or regulatory changes—only a fact-finding obligation with a 24-month reporting deadline.
What the text implies
- Study findings may expose insurance industry practices that restrict coverage for pain management during gynecologic procedures, potentially creating political pressure for coverage mandates.
- Inclusion of medical device manufacturers in stakeholder consultation may influence recommendations toward device-based solutions (e.g., regional anesthesia equipment) rather than pharmaceutical or procedural alternatives.
The full analysis lists 3 implications of this text.
Who stands to gain
medical device manufacturers (if recommendations favor device-based pain management solutions)